Cerebral dopamine neurotrophic factor (CDNF) protects against quinolinic acid-induced toxicity in in vitro and in vivo models of Huntington’s disease

por Stepanova, P., Srinivasan, V., Lindholm, D., Voutilainen, M. H.
Publicado 2020

Sigma-1 receptor agonist PRE084 is protective against mutant huntingtin-induced cell degeneration: involvement of calpastatin and the NF-κB pathway

por Hyrskyluoto, A, Pulli, I, Törnqvist, K, Huu Ho, T, Korhonen, L, Lindholm, D
Publicado 2013

Beneficial behavioral effects of chronic cerebral dopamine neurotrophic factor (CDNF) infusion in the N171-82Q transgenic model of Huntington’s disease

por Stepanova, P., Kumar, D., Cavonius, K., Korpikoski, J., Sirjala, J., Lindholm, D., Voutilainen, M. H.
Publicado 2023